Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | IGSF9 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | SEPT3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | CDC40 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | SYNCRIP | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | GALNT8 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | ZBTB24 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | CENPF | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | PCM1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |